Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TNNI3 Antikörper

TNNI3 Reaktivität: Human ELISA Wirt: Maus Monoclonal 11D2E10 unconjugated
Produktnummer ABIN1045363
  • Target Alle TNNI3 Antikörper anzeigen
    TNNI3 (Cardiac Troponin I (TNNI3))
    Reaktivität
    • 179
    • 93
    • 77
    • 21
    • 19
    • 17
    • 13
    • 10
    • 6
    • 4
    • 4
    • 4
    • 3
    • 1
    • 1
    • 1
    Human
    Wirt
    • 117
    • 96
    • 10
    • 4
    • 1
    • 1
    Maus
    Klonalität
    • 129
    • 92
    • 2
    Monoklonal
    Konjugat
    • 145
    • 20
    • 12
    • 9
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TNNI3 Antikörper ist unkonjugiert
    Applikation
    • 169
    • 100
    • 76
    • 42
    • 16
    • 14
    • 13
    • 13
    • 11
    • 11
    • 8
    • 7
    • 7
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA
    Spezifität
    Reacts equally with free cardiac troponin I and cardiac troponin I forming complexes with other troponin components. Not affected by heparin, phosphorylation and oxidation.
    Kreuzreaktivität
    Human
    Kreuzreaktivität (Details)
    No cross-reactivity with skeletal muscle troponin I.
    Aufreinigung
    Protein G purified
    Reinheit
    > 95 %
    Immunogen
    Recombinant Human Cardiac Troponin I protein
    Klon
    11D2E10
    Isotyp
    IgG2b
    Top Product
    Discover our top product TNNI3 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Kommentare

    Other species are not tested. Please decide the specificity by homology

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Handhabung
    Avoid freeze and thaw cycles.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Stein, Janjua, Matta, Pathak, Jaweesh, Alrifai, Chughtai: "Prognosis based on creatine kinase isoenzyme MB, cardiac troponin I, and right ventricular size in stable patients with acute pulmonary embolism." in: The American journal of cardiology, Vol. 107, Issue 5, pp. 774-7, (2011) (PubMed).

    Goel, Beith: "Troponin I as a predictor for trastuzumab-related cardiotoxicity: current data do not provide mechanistic insights or allow for incorporation into clinical practice." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 29, Issue 7, pp. e175-6, (2011) (PubMed).

    Xue, Clopton, Peacock, Maisel: "Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure." in: European journal of heart failure, Vol. 13, Issue 1, pp. 37-42, (2010) (PubMed).

    Paparella, Scrascia, Paramythiotis, Guida, Magari, Malvindi, Favale, de Luca Tupputi Schinosa: "Preoperative cardiac troponin I to assess midterm risks of coronary bypass grafting operations in patients with recent myocardial infarction." in: The Annals of thoracic surgery, Vol. 89, Issue 3, pp. 696-702, (2010) (PubMed).

    John, Woodward, Wang, Yan, Fisher, Kinasewitz, Heiselman: "Troponin-I as a prognosticator of mortality in severe sepsis patients." in: Journal of critical care, Vol. 25, Issue 2, pp. 270-5, (2010) (PubMed).

    van Geene, van Swieten, Noyez: "Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality." in: Interactive cardiovascular and thoracic surgery, Vol. 10, Issue 3, pp. 413-6, (2010) (PubMed).

    Napan, Kashinath, Kadri, Orig, Khadra: "Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention." in: Coronary artery disease, Vol. 21, Issue 5, pp. 261-5, (2010) (PubMed).

    Bonaca, Scirica, Sabatine, Dalby, Spinar, Murphy, Jarolim, Braunwald, Morrow: "Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I." in: Journal of the American College of Cardiology, Vol. 55, Issue 19, pp. 2118-24, (2010) (PubMed).

    Tsutamoto, Kawahara, Nishiyama, Yamaji, Fujii, Yamamoto, Horie: "Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure." in: American heart journal, Vol. 159, Issue 1, pp. 63-7, (2010) (PubMed).

    Oshima, Kunimoto, Takahashi, Mohara, Takeyoshi, Hinohara, Okawa, Saito: "Postoperative cardiac troponin I (cTnI) level and its prognostic value for patients undergoing mitral valve surgery." in: International heart journal, Vol. 51, Issue 3, pp. 166-9, (2010) (PubMed).

    Zahid, Good, Singla, Sonel: "Clinical significance of borderline elevated troponin I levels across different assays in patients with suspected acute coronary syndrome." in: The American journal of cardiology, Vol. 104, Issue 2, pp. 164-8, (2009) (PubMed).

    Fruchter, Yigla: "Cardiac troponin-I predicts long-term mortality in chronic obstructive pulmonary disease." in: COPD, Vol. 6, Issue 3, pp. 155-61, (2009) (PubMed).

    Alonso Martínez, Annicchérico Sánchez, Urbieta Echezarreta, García Sanchotena, Ezcurra Ibáñez, Lasa Inchausti: "[Clinical usefulness of troponin I in acute pulmonary embolism]." in: Medicina clínica, Vol. 133, Issue 6, pp. 201-5, (2009) (PubMed).

    Apple: "Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB." in: Clinica chimica acta; international journal of clinical chemistry, Vol. 284, Issue 2, pp. 151-9, (1999) (PubMed).

  • Target
    TNNI3 (Cardiac Troponin I (TNNI3))
    Andere Bezeichnung
    TNNI3 (TNNI3 Produkte)
    Synonyme
    CMD1FF antikoerper, CMD2A antikoerper, CMH7 antikoerper, RCM1 antikoerper, TNNC1 antikoerper, cTnI antikoerper, CMD1Z antikoerper, CMH13 antikoerper, TN-C antikoerper, TNC antikoerper, TNNC antikoerper, Tn1 antikoerper, TnIc antikoerper, ctnIc antikoerper, XTnIc antikoerper, c-troponin antikoerper, cTNT antikoerper, cmh7 antikoerper, ctni antikoerper, tnnc1 antikoerper, TNNI3 antikoerper, TnI antikoerper, cTNI antikoerper, AI874626 antikoerper, TnC antikoerper, cTnC antikoerper, tncc antikoerper, Tncc antikoerper, troponin I3, cardiac type antikoerper, troponin C1, slow skeletal and cardiac type antikoerper, troponin I, cardiac 3 antikoerper, troponin I type 3 (cardiac) antikoerper, troponin I3, cardiac type S homeolog antikoerper, troponin I3, cardiac type L homeolog antikoerper, cardiac troponin I antikoerper, troponin C, cardiac/slow skeletal antikoerper, TNNI3 antikoerper, TNNC1 antikoerper, Tnni3 antikoerper, tnni3.S antikoerper, tnni3.L antikoerper, tnni3 antikoerper, LOC100462680 antikoerper, Tnnc1 antikoerper
    Hintergrund

    Background: Troponin I is part of a heteromeric complex playing an important role in the regulation of skeletal and cardiac muscle contraction. It consists of three subunits, troponin I (TnI), troponin T (TnT) and troponin C (TnC). Each subunit is responsible for part of troponin complex function. TnI inhibits ATPase activity of acto myosin and TnT and TnI are present in cardiac muscles in different forms than in skeletal muscles. Only one tissue specific isoform of TnI is described for cardiac muscle tissue (cTnI) and this is expressed only in myocardium.

    Aliases: CTnI

    UniProt
    P19429
Sie sind hier:
Kundenservice